Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Thyroid Neoplasms 1Sarcoma, Ewing 1Pain 1Osteosarcoma 1Osteonecrosis 1Nasopharyngeal Carcinoma 1Motor Activity 1Lymphoma, Non-Hodgkin 1Lymphedema 1Leukemia 1Hodgkin Disease 1Exostoses, Multiple Hereditary 1Deglutition Disorders 1Colonic Neoplasms 1Chondrosarcoma 1Breast Neoplasms 1Bone Neoplasms 1Anemia, Sickle Cell 1

Interventions

Ibandronic Acid 8Gemcitabine 8Doxorubicin 6Cyclophosphamide 6Zoledronic Acid 5Radiation 4Nivolumab 4Irinotecan 4pembrolizumab 3Vincristine 3Temozolomide 3Magnetic Resonance Spectroscopy 3Ipilimumab 3Docetaxel 3Denosumab 3Cisplatin 33-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 3regorafenib 2pegfilgrastim 2Tranexamic Acid 2Trabectedin 2Surveys and Questionnaires 2Sunitinib 2Standard of Care 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Radiosurgery 2Quality of Life 2Proton Therapy 2Observation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bone Neoplasms × Range of Motion, Articular × Clear all
NCT03442465 2026-04-17

Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas

Memorial Sloan Kettering Cancer Center

Recruiting
300 enrolled
Sarcoma

Bone Neoplasms, Chondrosarcoma, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡